🇺🇸 FDA
Pipeline program

Sabin-Based Inactivated Poliomyelitis Vaccine (sIPV)

IPV-102

Phase 2 mab terminated

Quick answer

Sabin-Based Inactivated Poliomyelitis Vaccine (sIPV) for Poliomyelitis is a Phase 2 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Poliomyelitis
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials